| INTRODUCTION
Ureaplasma urealyticum is a kind of microorganism with the size between the size of virus and bacteria, which can exist independently or parasitically. Recently, the U. urealyticum infection incidence has risen up year by year and becomes an important pathogen in the female genitourinary tract infections, such as vaginosis, urethritis, cervicitis, pelvic inflammatory, and pyelonephritis. Moreover, the infection may further cause infertility, prematurity, and spontaneous abortion. The common treatment for the U. urealyticum is drug therapy, which however has become much more difficult as the drug resistance nature is getting much and more serious. 1 It is known that U. urealyticum consists of two types of biovars 1 However, the correlation between serovars and antimicrobial agents were nearly reported. In this study, we will detect the Ureaplasma urealyticum biovars and serovars in female patients with urogenital infections, and determine the relationship between different types of pathogens and their antimicrobial susceptibility.
| MATERIALS AND METHODS

| Samples
This study has been approved by the Ethical Committee of our hospital, and before the study, all the study subjects have given informed consent for participation. About 246 female outpatients (age 20-55)
including 125 female outpatients as the patient group and 121 healthy subjects as the control group from the gynecology and obstetrics clinics in our hospital were involved in the study. All cervical secretion specimens were examined within 48 hours after collection from July 2013 to July 2014.
| Reagents
The . The amplified products were subjected to 2% gel electrophoresis; a 2000 kb molecular marker was used to identify the product band sizes, which were 320 bp and 470 bp in size for U. parvum and U. urealyticum, respectively.
Statistical analysis was performed by using SPSS 17.0 software, Beijing, China. P < .05 indicates the statistical significance.
| RESULT
In total, 102 (41.46%) of 246 subjects were positive for U. urealyticum, among them, 72 were from the patient group (57.60%, 72/125) and 30 were from the control group (24.79%, 30/121, P<.01).
Among the 102 positive isolates, 75 have biovar 1 and 23 have biovar 2, the remaining four were found in four patients co-infected with both the biovars. The main serovars were 1, 3, 6 in biovar 1, and a mixed infection was observed in biovar 2. The distribution of U. urealyticum according to the biovars is given in Table 1 .
The distribution of resistant isolates in two biovars is depicted in Table 2 , biovar 1 was less resistant to sparfloxacin (**P<.01) and more resistant to azithromycin, minocycline, and doxycycline than biovar 2 (*P<.05).
The distribution of drug-resistant isolates in different serovars from biovar 1 is givenin Table 3 . The serovars S1, S3 and S6 have the highest resistant rate to azithromycin (90.90%), roxithromycin (84.62%), and ofloxacin (84.38%), repectively.
| Limitations of this study
We did not perform the Antimicrobial Susceptibility Test in the control group. Hence, we have no idea about the differences existing between the patient group and the control group.
| DISCUSSION
From the detection of U. urealyticum in liquid culture isolated from the female patients, we found that the total positive rate of U. urealyticum was 41.46%, and the infection rate of patient group (57.60%) was higher than that of the control group (24.79%), the difference was statistically significant (χ 2 = 16.550, P<.01). Qing-Yong et al. 5 reported that single infections with U. urealyticum were the most prevalent in easily infected by U. urealyticum may be associated with the physiological characteristics that the female reproductive tract is short and is more susceptible to be infected. At the early stage of infection, symptoms are not obvious, so the examination and treatment can be easily ignored. Finally, persistent and cross-infection will come up.
In this study, we aimed to evaluate the relationship between biovars and the antimicrobial resistance of U. urealyticum in female patients with urogenital infections. We found that among 102 positive isolates from the patient group, more biovar 1 was found than biovar 2, and four patients were co-infected with both the biovars. Chang-tai et al. 8 reported that biovar 1 was found in 73 (57.94%), which is in accordance with our results. According to the results of Antimicrobial Susceptibility Testing, we found that biovars 1 and 2 were more resistant to azithromycin (80.00%) and sparfloxacin (82.61%), respectively, than other drugs, hence these drugs should not be empirically used.
On the other side, we found that both biovars 1 and 2 were more sensitive to minocycline and doxycycline. However, biovar 1 shows much more resistance than biovar 2. The prevalence of antibiotic resistance profiles of U. urealyticum in our study differ from those reported by authors of similar studies. 
| CONCLUSION
In summary, U. urealyticum biological type and drug resistance were studied in this paper, which provided the basis for the clinical rational use of drugs in a certain extent. It is also suggested that the detection of biovars and serovars of U. urealyticum is necessary in clinical practice. We need to avoid resistant strains when using antimicrobial drugs to refer to the rational use of antimicrobial drugs, as far as possible to avoid resistant strains. *Represents there is significant difference among the serovars S1, S3 and S6 (*P < .01).
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